Dr Lincoln Chee
Lincoln has over 25 years of experience in healthcare as a surgeon, executive and investor. Lincoln is currently on the Boards of Earlens, Holaira, Visterra and Sensimed. Notable past investments include Twelve (acquired by Medtronic), Arana Therapeutics (acquired by Cephalon), Biosensors International (IPO) and Phoenix Hospital Group (IPO).
Prior to joining Vertex, Lincoln served as CEO and Board Member of Quality Healthcare, Hong Kong’s first publicly listed healthcare company. He led the growth and eventual buyout by Fortis Group in 2010. In 2009, Lincoln was selected as Outstanding Entrepreneur of HK. He also held committee positions with Hong Kong Government Food and Health Bureau on e-health Records and Primary Care Delivery Models and an advisory member of Hong Kong Trade and Development Council. Since 2013, Lincoln has been an operating partner advisor for Advent International in healthcare.
Lincoln holds a MBBS from the National University of Singapore. He is a Fellow of the Royal College of Surgeons Edinburgh and a Fellow Academy of Medicine Singapore in Otorhinolaryngology Head & Neck Surgery.
Lincoln was a member of Changi Sailing Club and was active in one design keelboats. He was an owner of and actively raced in JUNO, J-24 class in the 1990’s and participated in Sydney Hobart, King’s Cup and Raja Muda series.